Unbound MEDLINE

alosetron journal articles from PubMed MEDLINE database

Unbound MEDLINE results for:RSS FEEDBookmark this site
alosetron| Refine this search
1 - 10 of 246 journal articles in the PubMed databaseEmail to a friend    
 
Ford AC, Brandt LJ, Young C, et al. 
Efficacy of 5-HT(3) Antagonists and 5-HT(4) Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. [JOURNAL ARTICLE]
Am J Gastroenterol 2009 May 26.
Abstract | Full Citation | Find Related Articles 
Sikander A, Rana SV, Prasad KK 
Role of serotonin in gastrointestinal motility and irritable bowel syndrome. [JOURNAL ARTICLE]
Clin Chim Acta 2009 Feb 3.
Abstract | Full Citation
Jarcho JM, Chang L, Berman M, et al. 
Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Aliment Pharmacol Ther 2008 Aug 1; 28(3):344-52.
Abstract | Full Citation | Find Related Articles 
Sanger GJ 
5-hydroxytryptamine and the gastrointestinal tract: where next? [Journal Article]
Trends Pharmacol Sci 2008 Sep; 29(9):465-71.
Abstract | Full Citation
Moayyedi P, Cranney A 
Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm. [Journal Article, Research Support, Non-U.S. Gov't]
Am J Gastroenterol 2008 Oct; 103(10):2428-31.
Abstract | Full Citation
Fornai M, Colucci R, Antonioli L, et al. 
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders. [Journal Article]
Methods Find Exp Clin Pharmacol 2008 May; 30(4):261-9.
Abstract | Full Citation
Fayyaz M, Lackner JM 
Serotonin receptor modulators in the treatment of irritable bowel syndrome. [Journal Article]
Ther Clin Risk Manag 2008 Feb; 4(1):41-8.
Abstract | Full Citation | Find Related Articles 
Sanger GJ 
5-Hydroxytryptamine and the gastrointestinal tract: where next? [JOURNAL ARTICLE]
Trends Pharmacol Sci 2008 Aug 11.
Abstract | Full Citation | Find Related Articles 
Matsueda K, Harasawa S, Hongo M, et al. 
A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome. [JOURNAL ARTICLE]
Digestion 2008 Jun 10; 77(3-4):225-235.
Abstract | Full Citation | Find Related Articles 
Rahimi R, Nikfar S, Abdollahi M 
Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: A meta-analysis of eight randomized, placebo-controlled, 12-week trials. [Journal Article]
Clin Ther 2008 May; 30(5):884-901.
Abstract | Full Citation
New Search Next Results
  
Medical Software for Palm Pre now available

Advertise on this site.